null
null
OncologyStat
®
One Source, Many Resources.
®
By Elsevier
ESOPHAGUS CANCER
Refine Results:
All Categories
Epidemiology and Etiology (75)
Prevention and Screening (53)
Diagnosis and Staging (80)
Treatment (178)
Supportive Oncology (14)
News
FDA Adds Longer GIST Therapy to Imatinib Label
Elsevier Global Medical News, 2012 Feb 1, E Mechcatie
New Certification for Complex Surgical Oncology
Elsevier Global Medical News, 2012 Jan 19, F Correa
ASCO-GI Trial Data Show Progress
Elsevier Global Medical News, 2012 Jan 19, P Wendling
Smoking Doubles Cancer Risk in Barrett's Esophagus
Elsevier Global Medical News, 2012 Jan 5, D Napoli
Long-Term Risk of GI Cancers Not Elevated in Celiac Patients
Elsevier Global Medical News, 2011 Dec 7, D Napoli
More News ›
Journal Scans: Research
Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study
Int J Radiat Oncol Biol Phys, 2011 Dec 13, MT Milano, et al
Non-Steroidal Anti-Inflammatory Drug Use Reduces Risk for Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis
Gastroenterology, 2011 Nov 18, LM Liao, et al
Incidence of Adenocarcinoma Among Patients With Barrett's Esophagus
N Engl J Med, 2011 Oct 13, F Hvid-Jensen, et al
EXPERT COMMENTARY
The Value of Post-Neoadjuvant Therapy PET-CT in the Detection of Interval Metastases in Esophageal Carcinoma
Eur J Surg Oncol, 2011 Sept 1, RL Blom, et al
Phase II trial of Modified FOLFOX6 and Erlotinib in Patients With Metastatic or Advanced Adenocarcinoma of the Oesophagus and Gastro-Oesophageal Junction
Br J Cancer, 2011 Aug 2, ZA Wainberg, et al
More Journal Scans: Research ›
Journal Scans: Review
Lymph Node Metastases and Prognosis in Oesophageal Carcinoma—A Systematic Review
Eur J Surg Oncol, 2011 Sept 1, B Kayani, et al
Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer
Crit Rev Oncol Hematol, 2011 May 1, Karis K.F. Cheng, et al
Oesophagogastric Junction Adenocarcinoma: Which Therapeutic Approach?
Lancet Oncol, 2011 Mar 1, C Mariette, et al
The Safety and Effectiveness of Endoscopic and Non-Endoscopic Approaches to the Management of Early Esophageal Cancer: A Systematic Review
Cancer Treat Rev, 2011 Feb 16, P McCann, et al
DNA methylation in thoracic neoplasms
Cancer Lett, 2011 Feb 1, Chen Chen, et al
More Journal Scans: Review ›
Expert Opinion
Gastroesophageal Junction Adenocarcinoma: Interview With Dr. David Ilson
OncologySTAT Editorial Team, 2011 Jul 14, L Scott Zoeller
Oesophageal Cancer: Who Needs Neoadjuvant Therapy?
Lancet Oncol, 2011 Jul 1, TN Walsh
Dr. Jean-Yves Douillard: What You Need to Know About Gastrointestinal Studies Presented at ESMO
OncologySTAT Editorial Team, 2010 Oct 25, Interview by L Scott Zoeller
ASCO GI 2009: Seven Interesting Studies
2009 Feb 2, Axel Grothey, et al
Chemotherapy Regimens
XP (capecitabine [Xeloda], cisplatin [Platinol-AQ]) (Esophagus)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
XO (capecitabine [Xeloda], oxaliplatin) (Esophagus)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel, cisplatin, 5-fluorouracil (Esophagus)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel (with G-CSF) (Esophagus)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
MCF (mitomycin, cisplatin, 5-fluorouracil) (Esophagus)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›
Conference Coverage
2012 Gastrointestinal Cancers Symposium
Jan 19-21 2012 San Francisco, et al
Videos
Cancer in Nondysplastic Barrett's Esophagus
Elsevier Global Medical News, 2010 Jun 16, H Splete
Neoadjuvant Cetuximab and Chemoradiation
Elsevier Global Medical News, 2009 Jan 15, R Finn
Endoscopic Resection of Barrett's Esophagus
Elsevier Global Medical News, 2008 Sept 1, D McNamara
Summary of Key Points
Cancer of the Esophagus
Abeloff: Clinical Oncology, 3rd ed. 2004
Comment
Print page
Share page
RSS feeds
Updated Key Points: Esophagus Cancer
Summary information about esophagus cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›
Editors' Choice
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
Read more ›
Categories
News
Journal Scans
Expert Opinion
Drugs and Regimens
Conferences
CME
Videos
Supportive Care
Skeletal-Related Events
Complications, GI and Oral
Hematologic Support
Infectious Complications
Neurologic Complications
Pain
Vascular Complications
Cancer Type
Bladder
Bone
Breast
Breast (ER-Positive)
CNS/Brain
Colon and Rectum
Endocrine System
Esophagus
GYN (Non-Ovary)
GYN (Ovary)
Head and Neck
Hodgkin's Lymphoma
Kidney (Renal Cell)
Leukemia
Liver and Bile Duct
Lung
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Diseases
Non-Hodgkin's Lymphoma
Pancreas
Pediatric Cancers
Prostate
Rare Cancers
Skin
Soft-Tissue Sarcoma
Stomach
Testicle
Esophagus/
anonymous
none
none
none
n
Advanced Search
Email Address
Password
Remember Me
Forgot your password?
Not a member?
Free registration
Elsevier
Home
Site Map
Cancer Types
About OncologySTAT
Privacy Policy
Terms of Use
Contact Us
Advertise
Copyright © 2012
Elsevier Inc.
All rights reserved.